Pharmaceutical Sales Representative (Rare Disease)

Kaye/Bassman International is a leading Pharmaceutical and Biotechnology search firm, filling critical roles in eleven different verticals. Our Commercial search team is lead by industry expert Eduardo Marinero: is seeking a dynamic and highly motivated Rare Diseases Pharma Sales Representative in the state of Pennslyvania. As a vital member of our commercial organization, you will be responsible for driving sales and increasing market share of our innovative products targeting rare diseases. The ideal candidate will have a passion for improving patient outcomes, a deep understanding of the rare disease landscape, and a proven ability to build strong relationships with healthcare professionals.Key ResponsibilitiesSales and Account ManagementDevelop and execute a strategic sales plan to achieve territory sales goals and expand market presence.Build and maintain strong relationships with key opinion leaders (KOLs), healthcare providers, and specialists in rare disease treatment.Regularly meet with and educate stakeholders in clinics, hospitals, and academic institutions.Territory DevelopmentIdentify and engage with target healthcare professionals and institutions in/around the state of Pennslyvania.Stay informed about competitive products and industry trends related to rare diseases.Collaborate with internal teams (e.g., medical, marketing, and market access) to optimize territory performance and customer engagement.Patient SupportServe as a key liaison between healthcare professionals and patient support programs to ensure appropriate access to therapies.Educate physicians on patient assistance programs and reimbursement options for rare disease treatments.QualificationsExperienceMinimum of 3-5 years of pharmaceutical sales experience, with a strong preference for rare disease or specialty pharmaceutical sales.Proven track record of meeting or exceeding sales targets.If you fit the description, please apply. Also, feel free to join our private LinkedIn Job Board:

Created: 2025-02-02